Established in 2003, the UC Davis Genome Center uses state-of-art-technologies to understand how the heritable genetic information of diverse organisms function in health and disease. The combination of cutting-edge research facilities, diverse service cores, and talented staff make the Genome Center a world class facility for genomics research and training.
Research that makes a difference
A sample of questions being addressed by the UC Davis Genome Center faculty and their collaborators:
- How do variations in the human genome affect the risks of diseases such as cancer, coronary artery disease, and autism?
- Do infection, diet, or stress serve as environmental triggers of Type 1 diabetes?
- What novel, useful organisms will be discovered by sequencing microbes from extreme environments?
- Can characterization of the small chemicals in algae lead to new biofuels?
- How can we control diseases of important food crops?
- How can plants be modified to increase their productivity and quality?
- What changes can we make to proteins to enhance their performance?
- Can we model and predict life’s basic processes?
- How can we glean useful information from vast datasets?
Here are just some of the recent highlights involving people and projects at the Genome Center Please see the news page for a full list of all news items.
The Department of Pharmacology Proudly Present the Seminar Series: Frontiers in Pharmacology
“Beta-adrenergic receptor resensitization – an unsuspecting player in pathology”
Of the estimated 200 G-protein coupled receptors in the heart, beta adrenergic receptors (βARs) are considered one of the most powerful regulators of cardiac function and the most common ... Read more...
The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved a $1.1 million grant to UC Davis for research aimed at developing a treatment for Angelman syndrome, a rare, neurogenetic autism-spectrum disorder that occurs in one in 15,000 live births.
Because Angelman syndrome is caused by a maternal gene that is turned ... Read more...
‘Biophysics, Computational Biology and the Discovery of New Medicines: The Emergence of Resistance in Cancer and Tuberculosis’
May 11, 2016
The David L. Weaver Endowed Lecture Series in Biophysics and Computational Biology is dedicated to the memory of David L. Weaver, a prominent biophysics researcher and professor at Tufts University.
About Dr. Weaver
Dr. Weaver made significant contributions to the understanding of protein folding. He was impressed with ... Read more...
Genome Center researchers Alexandara Alexiev, Guillame Jospin, Jenna Lang, Professor Jonathan Eisen, and David Coil, in collaboration with Megan Krusor of the Department of Earth and Planetary Sciences, have published draft genome sequences of two strains of Pseudoalteromonas bacteria, isolated from root and leaf surfaces of the eelgrass Zostera marina. This research, part of the ... Read more...